BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 10193219)

  • 1. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
    Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
    Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB; Walker SC; Fontenot JP
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacodynamics of mivacurium preceded by atracurium or cisatracurium in children.
    Jalkanen L; Rautoma P; Taivainen T; Meretoja OA
    Anesth Analg; 1998 Jan; 86(1):62-5. PubMed ID: 9428852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
    Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
    Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
    Gibson FM; Mirakhur RK
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the duration of control stimulation on the onset and recovery of neuromuscular block.
    McCoy EP; Mirakhur RK; Connolly FM; Loan PB
    Anesth Analg; 1995 Feb; 80(2):364-7. PubMed ID: 7818125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
    Suzuki T; Lien CA; Belmont MR; Tjan J; Savarese JJ
    Can J Anaesth; 2003 Nov; 50(9):879-85. PubMed ID: 14617582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The onset of rocuronium, but not of vecuronium or mivacurium, is modified by tourniquet inflation.
    Audibert G; Donati F
    Anesth Analg; 1996 Apr; 82(4):848-53. PubMed ID: 8615509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative residual block after intermediate-acting neuromuscular blocking drugs.
    Hayes AH; Mirakhur RK; Breslin DS; Reid JE; McCourt KC
    Anaesthesia; 2001 Apr; 56(4):312-8. PubMed ID: 11284816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
    Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
    Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of action and intubating conditions following vecuronium, rocuronium and mivacurium.
    Wierda JM; Hommes FD; Nap HJ; van den Broek L
    Anaesthesia; 1995 May; 50(5):393-6. PubMed ID: 7793541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the recovery profile of mivacurium independent of the rate of decay of its plasma concentration in patients with normal plasma cholinesterase activity?
    Nijs N; Duvaldestin P; Slavov V; Dhonneur G
    Acta Anaesthesiol Scand; 1998 Nov; 42(10):1175-9. PubMed ID: 9834800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
    Itoh H; Shibata K; Nitta S; Kobayashi T
    Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium.
    Kansanaho M; Olkkola KT
    Int J Clin Monit Comput; 1996 Nov; 13(4):217-24. PubMed ID: 9080242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.